Business Context and Reporting Period
This Form 6-K filing by Smith & Nephew plc, dated July 23, 2026, serves as a timing announcement for the company's upcoming financial results. The filing pertains to the second quarter and first half of the fiscal year 2026, covering the period ended June 27, 2026. Smith & Nephew is a global medical technology company focused on orthopaedics, sports medicine, ENT, and advanced wound management, operating in approximately 100 countries with 17,000 employees.
Key Financial Metrics
The filing text does not provide specific financial results for the second quarter or first half of 2026, as this document is a pre-announcement of the release date. The only historical financial metric provided is the annual sales figure for the full year 2025, which was $6.2 billion. No data regarding revenue, profit, cash flow, margins, debt, or liquidity for the 2026 reporting period is present in this document.
Material Changes
As this filing contains no comparative financial data for the current period versus the prior period, no material changes in financial performance can be summarized. The document solely confirms the schedule for the upcoming results announcement.
Guidance, Outlook, and Risks
Outlook and Guidance: The company has not issued specific numerical guidance in this filing. It states that the official results and any associated commentary will be announced on Tuesday, August 4, 2026, at 7:00 am BST, followed by a conference call at 11:30 am BST.
Risks and Contingencies: The filing includes a comprehensive list of forward-looking statement risks, including:
- Geopolitical conflicts in Europe and the Middle East.
- Economic conditions affecting healthcare providers and payers.
- Regulatory approvals, reimbursement decisions, and government actions.
- Product defects, recalls, or quality management failures.
- Supply chain disruptions and cybersecurity threats.
- Foreign exchange volatility and changes in taxation regulations.
- Integration risks related to acquisitions and disposals.
Investor Verification Checklist
- Verify the official release of Q2 and H1 2026 results on August 4, 2026, via the company website or SEC filings.
- Confirm the details of the analyst conference call scheduled for August 4, 2026, at 11:30 am BST.
- Review the upcoming Form 20-F or earnings release for actual revenue, profit, and margin figures, as they are absent from this 6-K.
- Monitor for any updates on the specific risk factors listed, particularly regarding supply chain stability and regulatory environments in key markets.